MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Myotonic Dystrophy type 1 presenting as postural tremor

MJ. Lima, P. Ferreira, S. Moreira, M. Calejo (Senhora da Hora, Portugal)

Meeting: 2023 International Congress

Abstract Number: 1014

Keywords: Essential tremor(ET), Myotonic disorders, Parkinsonism

Category: Tremor

Objective: Description of a clinical case of extra-pyramidal features in a patient with myotonic dystrophy type 1.

Background: Myotonic dystrophy type 1 (MD-1) is an autosomal dominant muscular dystrophy, caused by abnormal expansion of unstable CTG trinucleotide repeats in the DMPK gene, with a multisystemic clinical syndrome, including additional ocular, cardiac, endocrine and cognitive involvement. Tremor can be a rare symptom.

Method: Case report.

Results: A 73-year old man, with a past medical record of vascular risk factors and atrial fibrillation, presented to the outpatient clinic with a 5-year history of upper limb tremor and progressive slowness of movements. On examination, he had slight bilateral ptosis and facial palsy, marked symmetric postural and rest hand tremor, left predominant slowness of movements and slight rigidity, postural instability and distal muscle weakness, with steppage gait. He had a family history of myotonic dystrophy type 1 but he had not been tested. Parkinsonism was suspected and levodopa was initiated, with only subjective clinical improvement. Subsequent study with needle electromyography demonstrated myotonic discharges, more proeminent in distal muscles. The genetic study revealed expansions of CTG repeats on the DMPK gene, which confirmed the diagnosis of MD-1. Due to clinical doubts, DaTSCAN imaging was requested and revealed to be normal.

Conclusion: Extrapyramidal manifestations have been increasingly recognized in patients with MD-2. Its description in MD-1 is restricted to a few case reports. The pathophisiology of these symptoms in MD remains poorly understood, but central nervous system involvement is suspected. In our case, postural and rest tremor was the presenting feature, along with symptoms suggestive of parkinsonism. Despite subjective response to levodopa treatment, DaTSCAN imaging didn’t confirm presynaptic dopaminergic deficit. This suggests a tremor syndrome similar to essential tremor with the confounding effects of muscle weakness, although the reported levodopa response is intriguing. Further studies are needed to better understand extrapyramidal features in MD.

To cite this abstract in AMA style:

MJ. Lima, P. Ferreira, S. Moreira, M. Calejo. Myotonic Dystrophy type 1 presenting as postural tremor [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/myotonic-dystrophy-type-1-presenting-as-postural-tremor/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/myotonic-dystrophy-type-1-presenting-as-postural-tremor/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley